Mankind Pharma FY25 ad spends up 25%

The company’s revenue has risen by 19% YoY to Rs 12,207 crore

e4m by e4m Staff
Published: Jul 16, 2025 1:06 PM  | 1 min read
Mankind Pharma
  • e4m Twitter

Mankind Pharma has ramped up its advertising and sales promotion spend by 25% to Rs 755.36 crore in FY2024-25, up from Rs 600.75 crore in the previous year. 

The pharmaceutical major, known for brands like Manforce Condoms and Prega News, has been focused with digital-first campaigns and celebrity endorsements. 

The company’s revenue has risen by 19 per cent YoY to Rs 12,207 crore. 

Profit after tax grew by 3.4% to Rs 2,007 crore, which the company said was impacted by increased finance costs tied to fresh borrowings.

Adjusted EBITDA rose 25% to Rs 3,159 crore, with margins improving to 25.9% on account of cost management.

Published On: Jul 16, 2025 1:06 PM